(VIANEWS) – RAMADA (RAM.LS), VIVENDI SE (VIV.PA), AHOLD DEL (AD.AS) are the highest payout ratio stocks on this list.
We have congregated information regarding stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. RAMADA (RAM.LS)
83.33% Payout Ratio
Ramada Investimentos e Industria, S.A. primarily operates in the steel and wire drawing business in Portugal and internationally. The company operates through Industry and Real Estate segments. It offers steel for use in the construction of machines and components; and production of tools, including dies, cutters, and moulds for industrial markets, such as plastic mold manufacturing, automotive industry components, capital goods, and components for household appliances and electronics. The company also manufactures and sells steel wires for the industrial, agriculture, and civil construction industries. In addition, it manages and leases real estate properties comprising forestry assets; and manages financial investments. The company was formerly known as F. Ramada Investimentos, SGPS, S.A. Ramada Investimentos e Industria, S.A. was founded in 1935 and is headquartered in Porto, Portugal.
Earnings Per Share
As for profitability, RAMADA has a trailing twelve months EPS of €0.35.
PE Ratio
RAMADA has a trailing twelve months price to earnings ratio of 18.4. Meaning, the purchaser of the share is investing €18.4 for every euro of annual earnings.
Sales Growth
RAMADA’s sales growth is negative 18.9% for the current quarter and 16% for the next.
More news about RAMADA.
2. VIVENDI SE (VIV.PA)
59.52% Payout Ratio
Vivendi SE operates as an entertainment, media, and communication company in France, the rest of Europe, the Americas, Asia/Oceania, and Africa. It operates through Canal+ Group, Lagardère, Havas, Prisma Media, Gameloft, Vivendi Village, New Initiatives, and Generosity and Solidarity segments. The Canal+ Group segment publishes and distributes premium and thematic pay-TV and free-to-air channels; and produces, sells, and distributes movies and TV series. The Lagardère segment engages in the publishing, media, and travel retail activities. The Havas segment includes communications disciplines, such as creativity, media expertise, and healthcare/wellness. The Prisma Media segment publishes French magazines and online videos. The Gameloft segment engages in the creation and publishing of downloadable video games for various console-PC-mobile platforms, tablets, triple-play boxes, and smart TVs. The Vivendi Village segment provides ticketing services and live performances through Olympia production, festival production, and venues. The New Initiatives segment operates Dailymotion, a video content aggregation and distribution platform, as well as develops ultra-high-speed Internet service. The Generosity and Solidarity segment operates CanalOlympia; and Vivendi Foundation, a Create Joy solidarity program, which supports initial and professional training projects. The company was founded in 1853 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, VIVENDI SE has a trailing twelve months EPS of €0.42.
PE Ratio
VIVENDI SE has a trailing twelve months price to earnings ratio of 24.05. Meaning, the purchaser of the share is investing €24.05 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.81%.
Yearly Top and Bottom Value
VIVENDI SE’s stock is valued at €10.10 at 07:10 EST, below its 52-week high of €10.54 and way above its 52-week low of €7.99.
More news about VIVENDI SE.
3. AHOLD DEL (AD.AS)
56.54% Payout Ratio
Koninklijke Ahold Delhaize N.V. operates retail food stores and e-commerce in the United States, Europe, and internationally. The company's stores offer produce, dairy, meat, deli, bakery, seafood, and frozen products; grocery, beer, and wine; floral, pet food, health and beauty care, kitchen and cookware, gardening tools, general merchandise articles, electronics, newspapers and magazines, tobacco, etc.; gasoline; and pharmacy products. It operates its supermarkets, convenience stores, and online stores under the Food Lion, Stop & Shop, The GIANT Company, Hannaford, Giant Food, FreshDirect, Albert Heijn, bol.com, Etos, Gall & Gall, Delhaize, Albert, Alfa Beta Vassilopoulos, Mega Image, Delhaize Serbia, Peapod Digital labs, and Retail Business Service brands. The company was formerly known as Koninklijke Ahold N.V. and changed its name to Koninklijke Ahold Delhaize N.V. in July 2016. Koninklijke Ahold Delhaize N.V. was founded in 1867 and is headquartered in Zaandam, the Netherlands.
Earnings Per Share
As for profitability, AHOLD DEL has a trailing twelve months EPS of €1.88.
PE Ratio
AHOLD DEL has a trailing twelve months price to earnings ratio of 14.76. Meaning, the purchaser of the share is investing €14.76 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.83%.
Yearly Top and Bottom Value
AHOLD DEL’s stock is valued at €27.74 at 07:10 EST, way under its 52-week high of €31.88 and above its 52-week low of €25.40.
Sales Growth
AHOLD DEL’s sales growth for the current quarter is 1%.
More news about AHOLD DEL.
4. NEURONES (NRO.PA)
54.19% Payout Ratio
Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. Its infrastructure services include infrastructure management, manages public and private cloud services, IT operations, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. The company also provides application services in the areas of SAP, digital, WEB, mobility, UX/UI, enterprise content and document management, business process management, robotic process automation, dematerialization, IT consulting for finance, big data, and DevOps, IT training and change management, and Innovation connected devices (IOT). In addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, DevOps, CI/CD, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, UX/UI, and digital marketing, as well as internal process digitization, ECM/BPM, RPA, dematerialization, AI, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. The company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. Neurones S.A. was founded in 1984 and is based in Nanterre, France.
Earnings Per Share
As for profitability, NEURONES has a trailing twelve months EPS of €1.96.
PE Ratio
NEURONES has a trailing twelve months price to earnings ratio of 23.37. Meaning, the purchaser of the share is investing €23.37 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.95%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 12, 2024, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 2.97%.
More news about NEURONES.
5. SARTORIUS STED BIO (DIM.PA)
42.86% Payout Ratio
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
Earnings Per Share
As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €3.36.
PE Ratio
SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 78.66. Meaning, the purchaser of the share is investing €78.66 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.15%.
Yearly Top and Bottom Value
SARTORIUS STED BIO’s stock is valued at €264.30 at 07:10 EST, below its 52-week high of €287.80 and way above its 52-week low of €146.45.
Revenue Growth
Year-on-year quarterly revenue growth declined by 8.2%, now sitting on 2.72B for the twelve trailing months.
Volume
Today’s last reported volume for SARTORIUS STED BIO is 48852 which is 29.49% below its average volume of 69287.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 10.9% and positive 44.7% for the next.
More news about SARTORIUS STED BIO.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Sales Growth
1’s sales growth is 1% for the present quarter and 1% for the next.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
More news about 1.
